| PTO Form 1963 (Rev 5/2006) |
| OMB No. 0651-0055 (Exp 07/31/2018) |
Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9
The table below presents the data as entered.
Input Field
|
Entered
|
| REGISTRATION NUMBER |
2663581 |
| REGISTRATION DATE |
12/17/2002 |
| SERIAL NUMBER |
75602363 |
| MARK SECTION |
| MARK |
ASTRAZENECA |
| ATTORNEY SECTION (current) |
| NAME |
Travis P. Boozer |
| FIRM NAME |
ASTRAZENECA PHARMACEUTICALS, LP |
| INTERNAL ADDRESS |
1800 CONCORD PIKE |
| STREET |
OW2 |
| CITY |
WILMINGTON |
| STATE |
Delaware |
| POSTAL CODE |
19850-5437 |
| COUNTRY |
United States |
| PHONE |
1 302 885 5242 |
| FAX |
1 302 886 8221 |
| EMAIL |
trademarks@astrazeneca.com |
| AUTHORIZED TO COMMUNICATE VIA E-MAIL |
Yes |
| ATTORNEY SECTION (proposed) |
| NAME |
Wm. Charles Saunders |
| FIRM NAME |
AstraZeneca Pharmaceuticals LP |
| INTERNAL ADDRESS |
FOP3-318 |
| STREET |
1800 Concord Pike |
| CITY |
WILMINGTON |
| STATE |
Delaware |
| POSTAL CODE |
19850-5437 |
| COUNTRY |
United States |
| PHONE |
302.885.4268 |
| FAX |
302.886.2952 |
| EMAIL |
trademarks@astrazeneca.com |
| AUTHORIZED TO COMMUNICATE VIA E-MAIL |
Yes |
| DOCKET/REFERENCE NUMBER |
Z20414/US |
| CORRESPONDENCE SECTION (current) |
| NAME |
TRAVIS P. BOOZER |
| FIRM NAME |
ASTRAZENECA PHARMACEUTICALS, LP |
| INTERNAL ADDRESS |
1800 CONCORD PIKE |
| STREET |
OW2 |
| CITY |
WILMINGTON |
| STATE |
Delaware |
| POSTAL CODE |
19850-5437 |
| COUNTRY |
United States |
| PHONE |
1 302 885 5242 |
| FAX |
1 302 886 8221 |
| EMAIL |
trademarks@astrazeneca.com |
| AUTHORIZED TO COMMUNICATE VIA E-MAIL |
Yes |
| CORRESPONDENCE SECTION (proposed) |
| NAME |
Wm. Charles Saunders |
| FIRM NAME |
AstraZeneca Pharmaceuticals LP |
| INTERNAL ADDRESS |
FOP3-318 |
| STREET |
1800 Concord Pike |
| CITY |
WILMINGTON |
| STATE |
Delaware |
| POSTAL CODE |
19850-5437 |
| COUNTRY |
United States |
| PHONE |
302.885.4268 |
| FAX |
302.886.2952 |
| EMAIL |
trademarks@astrazeneca.com;chuck.saunders@astrazeneca.com;paula.wright@astrazeneca.com |
| AUTHORIZED TO COMMUNICATE VIA E-MAIL |
Yes |
| DOCKET/REFERENCE NUMBER |
Z20414/US |
| GOODS AND/OR SERVICES SECTION |
| INTERNATIONAL CLASS |
005 |
| GOODS OR SERVICES |
Pharmaceuticals in the field of human medicine; |
| SPECIMEN FILE NAME(S) |
\\TICRS\EXPORT11\IMAGEOUT 11\756\023\75602363\xml1\ S890002.JPG |
| |
\\TICRS\EXPORT11\IMAGEOUT 11\756\023\75602363\xml1\ S890003.JPG |
| |
\\TICRS\EXPORT11\IMAGEOUT 11\756\023\75602363\xml1\ S890004.JPG |
| SPECIMEN DESCRIPTION |
images of product packaging |
| OWNER SECTION (current) |
| NAME |
ASTRAZENECA PLC |
| STREET |
15 STANHOPE GATE |
| CITY |
LONDON W1Y 6LN |
| COUNTRY |
United Kingdom |
| OWNER SECTION (proposed) |
| NAME |
ASTRAZENECA PLC |
| STREET |
2 Kingdom Street |
| CITY |
London |
| ZIP/POSTAL CODE |
W2 6BD |
| COUNTRY |
United Kingdom |
| LEGAL ENTITY SECTION (current) |
| TYPE |
PUBLIC LIMITED COMPANY |
| LEGAL ENTITY SECTION (proposed) |
| TYPE |
PUBLIC LIMITED COMPANY |
| STATE/COUNTRY WHERE LEGALLY ORGANIZED |
United Kingdom |
| PAYMENT SECTION |
| NUMBER OF CLASSES |
1 |
| NUMBER OF CLASSES PAID |
1 |
| SUBTOTAL AMOUNT |
500 |
| TOTAL FEE PAID |
500 |
| SIGNATURE SECTION |
| SIGNATURE |
/wcs/ |
| SIGNATORY'S NAME |
Wm. Charles Saunders |
| SIGNATORY'S POSITION |
Director, Trade Marks |
| DATE SIGNED |
02/28/2012 |
| SIGNATORY'S PHONE NUMBER |
302.885.4268 |
| PAYMENT METHOD |
DA |
| FILING INFORMATION |
| SUBMIT DATE |
Tue Feb 28 16:26:54 EST 2012 |
| TEAS STAMP |
USPTO/S08N09-XXX.XX.XXX.X
X-20120228162654834647-26
63581-49096bdb3ca68e2389b
8e5bd366e16583f-DA-3879-2
0120220104711050398 |
| PTO Form 1963 (Rev 5/2006) |
| OMB No. 0651-0055 (Exp 07/31/2018) |
Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9
To the Commissioner for Trademarks:
REGISTRATION NUMBER: 2663581
REGISTRATION DATE: 12/17/2002
MARK: ASTRAZENECA
The owner, ASTRAZENECA PLC, PUBLIC LIMITED COMPANY legally organized under the laws of United Kingdom, having an address of
2 Kingdom Street
London, W2 6BD
United Kingdom
is filing a Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9.
For International Class 005, the mark is in use in commerce on or in connection with
all goods/services, or to indicate membership in the collective membership organization, listed in the
existing registration for this specific class: Pharmaceuticals in the field of human medicine; ; or, the owner is making the listed excusable nonuse claim.
The owner is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in this class, consisting of a(n) images of product packaging.
Specimen File1
Specimen File2
Specimen File3
The registrant's current Attorney Information: Travis P. Boozer of ASTRAZENECA PHARMACEUTICALS, LP
1800 CONCORD PIKE
OW2
WILMINGTON, Delaware (DE) 19850-5437
United States
The registrant's proposed Attorney Information: Wm. Charles Saunders of AstraZeneca Pharmaceuticals LP
FOP3-318
1800 Concord Pike
WILMINGTON, Delaware (DE) 19850-5437
United States
The docket/reference number is Z20414/US.
The phone number is 302.885.4268.
The fax number is 302.886.2952.
The email address is trademarks@astrazeneca.com.
The registrant's current Correspondence Information: TRAVIS P. BOOZER of ASTRAZENECA PHARMACEUTICALS, LP
1800 CONCORD PIKE
OW2
WILMINGTON, Delaware (DE) 19850-5437
United States
The registrant's proposed Correspondence Information: Wm. Charles Saunders of AstraZeneca Pharmaceuticals LP
FOP3-318
1800 Concord Pike
WILMINGTON, Delaware (DE) 19850-5437
United States
The docket/reference number is Z20414/US.
The phone number is 302.885.4268.
The fax number is 302.886.2952.
The email address is trademarks@astrazeneca.com;chuck.saunders@astrazeneca.com;paula.wright@astrazeneca.com.
A fee payment in the amount of $500 will be submitted with the form, representing payment for 1 class(es), plus any additional grace period fee, if necessary.
Declaration
Section 8: Declaration of Use and/or Excusable Nonuse in Commerce
Unless the owner has specifically claimed excusable nonuse, the mark is in use in commerce on or in connection with the goods and/or services identified above, as evidenced by the attached
specimen(s) showing the mark as used in commerce.
The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements
and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own
knowledge are true and that all statements made on information and belief are believed to be true.
Section 9: Application for Renewal
The registrant requests that the registration be renewed for the goods/services/collective organization identified above.
Signature: /wcs/ Date: 02/28/2012
Signatory's Name: Wm. Charles Saunders
Signatory's Position: Director, Trade Marks
Signatory's Phone Number: 302.885.4268
Mailing Address
(current):
ASTRAZENECA PHARMACEUTICALS, LP
OW2
WILMINGTON, Delaware 19850-5437
Mailing Address
(proposed):
AstraZeneca Pharmaceuticals LP
1800 Concord Pike
WILMINGTON, Delaware 19850-5437
Serial Number: 75602363
Internet Transmission Date: Tue Feb 28 16:26:54 EST 2012
TEAS Stamp: USPTO/S08N09-XXX.XX.XXX.XX-2012022816265
4834647-2663581-49096bdb3ca68e2389b8e5bd
366e16583f-DA-3879-20120220104711050398
